HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cox, N. J. Articles by Bell, G. I. Search for Related Content PubMed PubMed Citation Articles by Cox, N. J. Articles by Bell, G. I. Social Bookmarking                What's this?

Linkage of Calpain 10 to Type 2 Diabetes

The Biological Rationale

¹ Department of Human Genetics, the University of Chicago, Chicago, Illinois
² Department of Medicine, the University of Chicago, Chicago, Illinois
³ Department of Biochemistry and Molecular Biology, the University of Chicago, Chicago, Illinois

The follow-up studies to the original report of association of variation at calpain 10 (CAPN10) with type 2 diabetes in the Mexican-American population of Starr County, Texas, encompass a broad range of science. There are association studies on genetic variation at CAPN10 in different human populations over a range of phenotypes related to type 2 diabetes, physiological studies on the biological functions of calpain proteases, and evolutionary studies on CAPN10 and the NIDDM1 region. We review here the studies published to date on CAPN10, as well as the latest findings from positional cloning studies on a number of other complex disorders. Collectively, these studies provide perspective on the challenges of moving from the linkage mapping and positional cloning studies on which we have been focused to an understanding of the biology shaping the relationship of genotype to phenotype at loci influencing susceptibility to complex disorders like type 2 diabetes.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Meier, H. H Klein, J. Kramer, M. Drenckhan, and M. Schutt Calpain inhibition impairs glycogen syntheses in HepG2 hepatoma cells without altering insulin signaling J. Endocrinol., April 1, 2007; 193(1): 45 - 51. [Abstract] [Full Text] [PDF]

				D. Cuerrier, T. Moldoveanu, R. L. Campbell, J. Kelly, B. Yoruk, S. H. L. Verhelst, D. Greenbaum, M. Bogyo, and P. L. Davies Development of Calpain-specific Inactivators by Screening of Positional Scanning Epoxide Libraries J. Biol. Chem., March 30, 2007; 282(13): 9600 - 9611. [Abstract] [Full Text] [PDF]

				H. Freeman and R.D. Cox Type-2 diabetes: a cocktail of genetic discovery Hum. Mol. Genet., October 15, 2006; 15(suppl_2): R202 - R209. [Abstract] [Full Text] [PDF]

				S. C. L. Gough and M. C. O'Donovan Clustering of metabolic comorbidity in schizophrenia: a genetic contribution? J Psychopharmacol, November 1, 2005; 19(6_suppl): 47 - 55. [Abstract] [PDF]

				I Richard The genetic and molecular bases of monogenic disorders affecting proteolytic systems J. Med. Genet., July 1, 2005; 42(7): 529 - 539. [Abstract] [Full Text] [PDF]